Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Biocon Biologics Uk Ltd

Clinical trials sponsored by Biocon Biologics Uk Ltd, explained in plain language.

Now part of Biocon Limited BIOCON NSE

Biologics arm of Biocon, developing biosimilars and novel biologics.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Completed 2 Terminated 1

Cheaper breast cancer drug copy put to the test – but trial ends early

Disease control Terminated

This phase 3 study tested a biosimilar called PERT-IJS against the original drug Perjeta, both given with standard chemotherapy, in women with early or locally advanced HER2-positive breast cancer. The goal was to see if the biosimilar works just as well at eliminating cancer bef…

Phase: PHASE3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC